Clinical Trial Update: Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gemcitabine as maintenance therapy in patients with extensive small cell lung cancer. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)

Snippet

Sponsor: Fudan University | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN